BRAF and neoplasm: Other experts hold that BRAF V600E alone lacks sufficient specificity and independent prognostic power, as its predictive value often diminishes when adjusted for conventional factors such as tumor size or metastasis; hence, they do not recommend it for use in isolation and suggest it should be considered alongside other genetic alterations for more accurate prognostication (9, 10).